DE69333723D1 - Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen - Google Patents

Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Info

Publication number
DE69333723D1
DE69333723D1 DE69333723T DE69333723T DE69333723D1 DE 69333723 D1 DE69333723 D1 DE 69333723D1 DE 69333723 T DE69333723 T DE 69333723T DE 69333723 T DE69333723 T DE 69333723T DE 69333723 D1 DE69333723 D1 DE 69333723D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparation
dermatological diseases
rhamnolipide
preparation based
rhamnolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333723T
Other languages
English (en)
Other versions
DE69333723T2 (de
Inventor
Biomedical Inc New Yo Paradigm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69333723D1 publication Critical patent/DE69333723D1/de
Publication of DE69333723T2 publication Critical patent/DE69333723T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
DE69333723T 1992-02-04 1993-02-04 Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen Expired - Lifetime DE69333723T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
BE9200115A BE1005704A4 (nl) 1992-02-04 1992-02-04 Farmaceutisch preparaat op basis van rhamnolipide.
BE9200115 1992-02-04
US86669192A 1992-04-10 1992-04-10
US866691 1992-04-10
PCT/EP1993/000270 WO1993014767A2 (en) 1992-02-04 1993-02-04 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections

Publications (2)

Publication Number Publication Date
DE69333723D1 true DE69333723D1 (de) 2005-01-20
DE69333723T2 DE69333723T2 (de) 2005-12-08

Family

ID=25662615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333723T Expired - Lifetime DE69333723T2 (de) 1992-02-04 1993-02-04 Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen

Country Status (11)

Country Link
EP (1) EP0630252B1 (de)
JP (2) JP3860206B2 (de)
AT (1) ATE284697T1 (de)
AU (1) AU3453493A (de)
BE (1) BE1005704A4 (de)
CA (1) CA2129542C (de)
DE (1) DE69333723T2 (de)
DK (1) DK0630252T3 (de)
ES (1) ES2235155T3 (de)
PT (1) PT630252E (de)
WO (1) WO1993014767A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
WO1999043334A1 (en) * 1998-02-24 1999-09-02 Tatjana Piljac Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
EP1889623A3 (de) * 1998-02-24 2009-04-08 Paradigm Biomedical Inc. Verwendung von Rhamnolipiden für die Wundheilung, für die Behandlung von Verbrennungen, Arteriosklerose, Organtransplantationen, Depressionen und Schizophrenie sowie für Kosmetikartikel
WO2001010447A1 (en) * 1999-08-05 2001-02-15 Tamara Stipcevic Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
US20040242501A1 (en) * 2003-03-20 2004-12-02 Gross Richard A. Spermicidal and virucidal properties of various forms of sophorolipids
DE102005052210A1 (de) * 2005-10-26 2007-05-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Mikrobiologisch stabilisiertes Bier
EP2046930A4 (de) * 2006-07-27 2012-06-27 Aurora Advance Beauty Labs Auf rhamnolipid basierende formulierungen
DK2648742T3 (da) 2010-12-09 2019-07-15 Y&B Mothers Choice Ltd Formuleringer indeholdende saponiner og anvendelser deraf
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
DE102012221519A1 (de) * 2012-11-26 2014-05-28 Evonik Industries Ag Verfahren zur Isolierung von Rhamnolipiden
EP2786742A1 (de) * 2013-04-02 2014-10-08 Evonik Industries AG Kosmetika enthaltend Rhamnolipide
DE102013205756A1 (de) * 2013-04-02 2014-10-02 Evonik Industries Ag Mischungszusammensetzung enthaltend Rhamnolipide
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
EP3192519A4 (de) * 2014-06-20 2018-03-14 Joint Center For Biosciences Zusammensetzung mit nährlösungsextrakt aus pseudomonas aeruginosa mit antibiotischer und antiseptischer wirkung und verwendung davon
EP3338762A1 (de) * 2016-12-22 2018-06-27 L'oreal Verwendung von rhamnolipid zur behandlung von hautrötung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4814953B1 (de) * 1970-10-14 1973-05-11
JPS60183032A (ja) * 1984-03-02 1985-09-18 Shiseido Co Ltd 乳化組成物
DD248279A1 (de) * 1984-09-07 1987-08-05 Univ Leipzig Antiphytovirale therapie mit biogenen mitteln
JPS6377533A (ja) * 1986-09-18 1988-04-07 Fujitsu Ltd 減圧処理装置の圧力切り替え方法
JPS63253025A (ja) * 1987-04-09 1988-10-20 Yamanouchi Pharmaceut Co Ltd ホスホリパ−ゼａ↓２阻害剤
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation

Also Published As

Publication number Publication date
JP3860206B2 (ja) 2006-12-20
DE69333723T2 (de) 2005-12-08
JPH09503196A (ja) 1997-03-31
PT630252E (pt) 2005-04-29
WO1993014767A3 (en) 1993-09-02
EP0630252A1 (de) 1994-12-28
ES2235155T3 (es) 2005-07-01
BE1005704A4 (nl) 1993-12-21
ATE284697T1 (de) 2005-01-15
EP0630252B1 (de) 2004-12-15
AU3453493A (en) 1993-09-01
CA2129542C (en) 2008-04-22
JP2004149547A (ja) 2004-05-27
DK0630252T3 (da) 2005-04-04
CA2129542A1 (en) 1993-08-05
WO1993014767A2 (en) 1993-08-05

Similar Documents

Publication Publication Date Title
ATE284697T1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
NO950297L (no) Prolinamidderivater
ATE181080T1 (de) Hiv-proteaseinhibitoren
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DE69206876D1 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
KR890003382A (ko) 항 비루스성 화합물
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
FI922044A (fi) Ny polypeptid och daerav framstaelld hiv-medicin.
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
FI911875A0 (fi) Kirala 2-(fosfonometoxi) propylguaniner som antivirala aemnen.
FI964303A0 (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
MX9206930A (es) Nuevos compuestos
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
KR930016417A (ko) 피롤릴벤조디아제핀온
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
NO903585D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
DK653687A (da) Middel til behandling af nyresygdomme
KR920002139A (ko) 뇌혈관 수축 치료제
KR960037045A (ko) B형 바이러스(hbv)성 간염의 예방 및 치료용 약학적 제제
DE69704759D1 (de) Ellipticinederivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition